Revenue
attach_money65M USD
YoY -3.4%
ENTAEnanta Pharmaceuticals, Inc.$ --
Enanta Pharmaceuticals, Inc.
ENTA
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 09/30/2025
Operating Income
bar_chart-85M USD
YoY +29.9%
Net Income
verified-82M USD
YoY +29.4%
EPS
pie_chart-3.84USD
YoY +29.9%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
17M
13M
9M
4M
0
2025/Q3
2025/Q4
2026/Q1
2026/Q2
Full-Year Progress
Net Income Progress41.4%Below Target
Revenue Progress35.8M
Revenue Forecast66.5M
Net Income Progress-25M
Net Income Forecast-60.4M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.